Tully Thomas P, Bergum James S, Schwarz Steven R, Durand Susan C, Howell Jeffrey M, Patel Ramesh N, Cino Paul M
Enzyme Technology, Process Research and Development, Bristol-Myers Squibb Pharmaceutical Research Institute, P. O. Box 191, New Brunswick, NJ 08903, USA.
J Ind Microbiol Biotechnol. 2007 Mar;34(3):193-202. doi: 10.1007/s10295-006-0186-0. Epub 2006 Nov 28.
BMS-353645, also known as sordarin, was of interest based on its activity against pathogenic fungi. The objective of these studies was to provide high quality starting substrate for chemical modification aimed at further improving biological activity, with particular interest in the inhibition of Aspergillus. In the work presented here, Design of Experiments, or DOE, was successfully combined with traditional approaches to significantly improve sordarin yields in fermentation flasks. Overall, yields were increased 25-fold from <100 microg/g to as high as 2,609 microg/g in flasks through the use of various medium and conduction changes supplemented with DOE. The improved process was then successfully scaled to pilot plant tanks with the best batch producing 2,389 microg/g sordarin at the 250-l scale.
BMS-353645,也被称为索德菌素,因其对致病真菌的活性而受到关注。这些研究的目的是提供高质量的起始底物用于化学修饰,以进一步提高生物活性,尤其关注对曲霉菌的抑制作用。在本文所述的工作中,实验设计(DOE)成功地与传统方法相结合,显著提高了发酵瓶中索德菌素的产量。总体而言,通过使用各种培养基并结合DOE进行传导变化,发酵瓶中的产量从低于100微克/克提高了25倍,高达2609微克/克。然后,改进后的工艺成功扩大到中试工厂罐体,在250升规模下,最佳批次生产出2389微克/克的索德菌素。